Unlocking the Stratum Corneum Barrier to Skin Penetration for the Transdermal Delivery of Cyclovirobuxine D
2024

Improving Skin Penetration of Cyclovirobuxine D for Transdermal Delivery

Sample size: 9 publication 10 minutes Evidence: high

Author Information

Author(s): Ren Yun-Hao, Song Feng-Yuan, Zhao Jing-Yu, Liang Bing-Wen, Peng Li-Hua, Skalko-Basnet Natasa, Muzzalupo Rita

Primary Institution: College of Pharmaceutical Sciences, Zhejiang University

Hypothesis

Can chemical penetration enhancers and niosomes improve the skin penetration of cyclovirobuxine D?

Conclusion

The combination of niosomes and chemical penetration enhancers significantly enhances the transdermal delivery of cyclovirobuxine D.

Supporting Evidence

  • Azone increased skin penetration of cyclovirobuxine D by 4.55 times compared to the untreated group.
  • Niosomes enhanced skin penetration by 1.50-fold.
  • The combination of azone and niosomes achieved an 8.10-fold increase in skin penetration.
  • Transdermal delivery minimizes the risk of overdose associated with oral or injectable administration.
  • Chemical penetration enhancers and nanotechnology are effective strategies for transdermal delivery.

Takeaway

This study found a way to help a medicine called cyclovirobuxine D get through the skin better, which could make it work better for treating diseases.

Methodology

The study used in vitro and in vivo experiments to test the skin penetration of cyclovirobuxine D with various chemical enhancers and niosomes.

Limitations

The study primarily focused on animal models, which may not fully represent human responses.

Participant Demographics

Sprague-Dawley rats and New Zealand white rabbits were used in the experiments.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/pharmaceutics16121600

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication